These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 21520036)

  • 41. The role of clinical criteria, genetic and epigenetic alterations in Lynch-syndrome diagnosis.
    Alemayehu A; Tomkova K; Zavodna K; Ventusova K; Krivulcik T; Bujalkova M; Bartosova Z; Fridrichova I
    Neoplasma; 2007; 54(5):391-401. PubMed ID: 17688369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.
    Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ
    Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
    Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
    Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microsatellite instability and colorectal cancer.
    Geiersbach KB; Samowitz WS
    Arch Pathol Lab Med; 2011 Oct; 135(10):1269-77. PubMed ID: 21970482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.
    Gausachs M; Mur P; Corral J; Pineda M; González S; Benito L; Menéndez M; Espinàs JA; Brunet J; Iniesta MD; Gruber SB; Lázaro C; Blanco I; Capellá G
    Eur J Hum Genet; 2012 Jul; 20(7):762-8. PubMed ID: 22274583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer.
    Siraj AK; Prabhakaran S; Bavi P; Bu R; Beg S; Hazmi MA; Al-Rasheed M; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS
    Cancer; 2015 Jun; 121(11):1762-71. PubMed ID: 25712738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.
    Rahner N; Friedrichs N; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
    J Pathol; 2008 Jan; 214(1):10-6. PubMed ID: 17973250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility.
    Crépin M; Dieu MC; Lejeune S; Escande F; Boidin D; Porchet N; Morin G; Manouvrier S; Mathieu M; Buisine MP
    Hum Mutat; 2012 Jan; 33(1):180-8. PubMed ID: 21953887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
    Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
    Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
    Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lynch syndrome in the hands of pathologists].
    Daum O; Beneš Z; Hadravský L; Stehlík J; Cerná K; Dušek M; Kokošková B; Michal M
    Cesk Patol; 2014 Jan; 50(1):18-24. PubMed ID: 24624982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathological characteristics of Lynch-like syndrome.
    Nakamori S; Takao M; Takao A; Natsume S; Iijima T; Kojika E; Nakano D; Kawai K; Inokuchi T; Fujimoto A; Urushibara M; Horiguchi SI; Ishida H; Yamaguchi T
    Int J Clin Oncol; 2024 Jul; 29(7):944-952. PubMed ID: 38642190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population-based molecular screening for Lynch syndrome: implications for personalized medicine.
    Ward RL; Hicks S; Hawkins NJ
    J Clin Oncol; 2013 Jul; 31(20):2554-62. PubMed ID: 23733757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria.
    Crucianelli F; Tricarico R; Turchetti D; Gorelli G; Gensini F; Sestini R; Giunti L; Pedroni M; Ponz de Leon M; Civitelli S; Genuardi M
    Epigenetics; 2014 Oct; 9(10):1431-8. PubMed ID: 25437057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers.
    Svrcek M; Buhard O; Colas C; Coulet F; Dumont S; Massaoudi I; Lamri A; Hamelin R; Cosnes J; Oliveira C; Seruca R; Gaub MP; Legrain M; Collura A; Lascols O; Tiret E; Fléjou JF; Duval A
    Gut; 2010 Nov; 59(11):1516-26. PubMed ID: 20947886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.